Total Funding
36
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 36 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
93392
10xBio, LLC, a privately-held biotechnology company
John Dobak: ChairmanPast Role: DermTech, Founder & CEO- Dan Piacquadio: Managing DirectorPast Role: University of California San Diego, Director
About the Company
10xBio is a biotechnology company that focuses on new uses for existing therapies and technologies. This strategy allows us to build on existing safety profiles and leverage known mechanisms of action, resulting in a streamlined development and regulatory process. Their most advanced asset, 10XB101, is a pharmaceutical product that addresses unmet
needs in dermatologic medicine.